Image

    Dihydroartemisinin Attenuates Benign Prostatic Hyperplasia in Rats by Inhibiting Prostatic Epithelial Cell Proliferation

    August 2021 in “ Annals of Translational Medicine
    Bo Zhang, Xiang Chen, Yu Gan … Yao He
    Studysummary In this study, dihydroartemisinin reduced prostate enlargement and related markers in a rat model of benign prostatic hyperplasia, suggesting its potential as a therapeutic agent.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on atm.amegroups.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Finasteride and Androgenic Alopecia: From Therapeutic Options to Medical Implications Journal of Dermatological Treatment · 2019
    2. Effects of Lespedeza Cuneata Aqueous Extract on Testosterone-Induced Prostatic Hyperplasia Pharmaceutical biology · 2019
    3. An Overview on 5α-Reductase Inhibitors Steroids · 2009